Eva M Grössinger Selected Research

Lipopolysaccharides

1/2017

Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva M Grössinger Research Topics

Disease

3	Inflammation (Inflammations) 01/2018 - 01/2017
3	Arthritis (Polyarthritis) 01/2018 - 01/2017
2	Bone Resorption 01/2018 - 01/2017
1	Ischemic Stroke 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2017
1	Ischemia 12/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016
1	Stroke (Strokes) 12/2016
1	Infarction (Infarctions) 12/2016
1	Neuroinflammatory Diseases 12/2016

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2018 - 01/2017
2	Interleukin-23 (Interleukin 23)IBA 01/2018 - 01/2017
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2018
1	Interleukin-27 (Interleukin 27)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Leukotriene B4IBA 01/2017
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2017
1	InterferonsIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 12/2016
1	TRAM 34IBA 12/2016